November 3, 2010

An article was published in the November edition of the Pancreas Journal summarizing the consensus from this conference. Full text version can be found here:
Interventions for Necrotizing Pancreatitis

Videos taken on the day of the meeting are now available!


1. What are the main points in the revision of Atlanta classification with regards to pancreatic and/or peripancreatic necrosis excluding nomenclature of collections?

Michael Sarr, MD – Mayo Clinic


2. What is the current nomenclature of collections in Atlanta classification and what is the need for revisions?

Thomas Bollen, MD – Brigham & Women’s Hospital



3. When is MRI/MRCP, plus minus secretin/gadolinium indicated in necrosis?

What is the role of secretin MRCP in defining disconnected duct?

Desiree Morgan, MD – University of Alabama at Birmingham


4. What is the role of EUS, MRCP, CT in differentiating necrosis from pseudocyst?

How much debris in a “pseudocyst” should suggest management as necrosis instead?

George Papachristou, MD – University of Pittsburgh


5. How is infected necrosis diagnosed?

In 2010, is FNA any longer indicated to diagnose IN?

Scott Tenner, MD, MPH – SUNY Downstate


6. When is intervention indicated for sterile and infected necrosis?

Is there a role for medical management for infected necrosis?

Peter Layer, MD – Iraelitic Hospital in Hamburg


7. Consensus Discussion

Facilitators: Tim Gardner, MD, Darwin Conwell, MD &

Tooru Shimosegawa, MD, PhD


8. In 2010,When is open surgical management of PN indicated

and when is it to be avoided, if possible?

Carlos Fernandez-del Castillo, MD – Massachusetts General Hospital


9. If open debridement is to be performed, which technique has

best results?

Bettina Rau, MD – University of Rostock


10. Consensus Discussion

Facilitators: Andrew Warshaw, MD, Peter Banks, MD &

Hans Beger, MD


11. What are the approaches to minimally invasive necrosectomy?

John Windsor, MD – University of Auckland


12. What are the results with intraperitoneal laparoscopic approach?

Dilip Parekh, MD – University of Southern California


13. What are the results with retroperitoneal sinus track approach?

Ross Carter, MD – Glasgow Royal Infirmary Pancreatic Team


14. What are the results with STEP-UP approach?

Hjalmar VanSantvoort, MD – University Medical Center, Utrecht


15. Consensus Discussion

Facilitators: Marc Besselink, MD, PhD, Jeffrey B. Matthews, MD & Jens Werner, MD


16. What are the results of percutaneous-only approach to debridement of necrosis?

When is it indicated?

Koenraad Mortele, MD – Brigham & Women’s Hospital


17. What are the results of combined percutaneous endoscopic approach?

Andrew Ross, MD – Virginia Mason Medical Center


18. What are the various techniques of endoscopic necrosectomy?

David Carr-Locke, MD – Beth Israel Medical Center


19. When is EUS-guidance indicated for endoscopic necrosectomy?

Shyam Varadarajulu, MD – University of Alabama at Birmingham


20. What are the challenges and future directions of transgastric debridement?

Todd H. Baron, MD – Mayo Clinic


21. What are results of European multicenter series of necrosectomy?

Hans Seifert, MD – Klinikum Oldenburg


22. What are the results of the systematic review on percutaneous drainage as a primary treatment of necrotizing pancreatitis ?

What are the results from the PENGUIN trial on endoscopy necrosectomy versus surgical necrosectomy?

Marc Besselink, MD, PhD – University Medical Center, Utrecht


23. What are the outcomes of endoscopic management of disconnected pancreatic duct and recurrent fistula/PFCs?

Olivier Le Moine, MD, PhD – Hopital Erasme


24. What are the outcomes of surgical management for disconnected pancreatic duct and recurrent fistula/PFC?

Greg Beilman, MD – University of Minnesota


25. Consensus Discussion

Facilitators: Stefan Seewald, David Carr-Locke



Facilitators: Santhi Swaroop Vege, MD & Martin Freeman, MD


27. Wrap up/Consensus Discussion

Facilitators: Santhi Swaroop Vege, MD & Martin Freeman, MD